Archive: The Promise of Plasma Proteomics in the Clinical Laboratory: Fact and Fiction

937 views · Published 15 July 2014 · 57:53 · Indexed 31 October 2026

Channel: UW Video · 2014 · Education

Watch on YouTube

The striking shortfall in new protein diagnostics emerging from proteomics research reflects a lack of critical biomarker verification capacity, in combination with other factors underlying the conservative stance of the in-vitro diagnostics (IVD) industry. In order to bridge the gap between biomarker discovery and clinical use, a new approach to verification is proposed: multiplexed panels of specific candidate assays based on hybrid immuno-mass spectrometric detection. By combining high-sensitivity, throughput, and precision with use of very small plasma samples, a platform for systematic verification of hundreds of candidates in thousands of samples can be implemented. Dr. N. Leigh Anderson shares the potential role of mass spectrometry for protein measurement in the routine clinical laboratory.

N. Leigh Anderson, Ph.D.
The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.

More from this channel